Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 14;10(9):1191.
doi: 10.3390/pathogens10091191.

Tracing Viral Transmission and Evolution of Bovine Leukemia Virus through Long Read Oxford Nanopore Sequencing of the Proviral Genome

Affiliations

Tracing Viral Transmission and Evolution of Bovine Leukemia Virus through Long Read Oxford Nanopore Sequencing of the Proviral Genome

Laura A Pavliscak et al. Pathogens. .

Abstract

Bovine leukemia virus (BLV) causes Enzootic Bovine Leukosis (EBL), a persistent life-long disease resulting in immune dysfunction and shortened lifespan in infected cattle, severely impacting the profitability of the US dairy industry. Our group has found that 94% of dairy farms in the United States are infected with BLV with an average in-herd prevalence of 46%. This is partly due to the lack of clinical presentation during the early stages of primary infection and the elusive nature of BLV transmission. This study sought to validate a near-complete genomic sequencing approach for reliability and accuracy before determining its efficacy in characterizing the sequence identity of BLV proviral genomes collected from a pilot study made up of 14 animals from one commercial dairy herd. These BLV-infected animals were comprised of seven adult dam/daughter pairs that tested positive by ELISA and qPCR. The results demonstrate sequence identity or divergence of the BLV genome from the same samples tested in two independent laboratories, suggesting both vertical and horizontal transmission in this dairy herd. This study supports the use of Oxford Nanopore sequencing for the identification of viral SNPs that can be used for retrospective genetic contact tracing of BLV transmission.

Keywords: Oxford Nanopore Sequencing; bovine leukemia virus; phylogenetics; proviral load; retroviral evolution; targeted sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
DNA dot plot matrix showing 100% similarity between sequences derived from Oxford Nanopore Technology (ONT) and Scheme 16s rDNA (A) or Thioredoxin gene (B) from two different mastitis-causing pathogens. (A): Corynebacterium bovis and (B): Mycoplasma bovis.
Figure 2
Figure 2
Experimental workflow for inter-laboratory technical replication of long-range BLV genome PCR amplification and Oxford Nanopore Sequencing.
Figure 3
Figure 3
Electrophoretograms showing the amplification, size, and integrity of BLV amplicons used for Oxford Nanopore Sequencing developed by the UMN and CentralStar methods. The coverage and number of trimmed reads used for mapping to the BLV genome is provided below each lane corresponding to the sample. Samples from CentralStar and UMN laboratories are appended with the letters “CS” and “UMN” respectively following the dam or daughter pair number. NTC: Non-Template Control.
Figure 4
Figure 4
Phylogenetic tree of BLV genomes derived from amplicons generated in the CentralStar and University of Minnesota laboratories displaying vertical and horizontal transmission between the dam-daughter pairs. Trees were inferred using maximum likelihood methods and supported with bootstrap value above 70. Different pairs are shown in different colors. Samples from CentralStar and UMN laboratories are appended with the letters “CS” and “UMN” respectively following the dam or daughter pair number.
Figure 5
Figure 5
Phylogenetic tree of env gene derived from sequences generated from the CentralStar laboratory. Different pairs are shown in different colors. Trees were inferred using maximum likelihood methods and supported with bootstrap value above 70.

References

    1. Gutiérrez G., Rodríguez S.M., De Brogniez A., Gillet N., Golime R., Burny A., Jaworski J.P., Alvarez I., Vagnoni L., Trono K., et al. Vaccination against δ-Retroviruses: The Bovine Leukemia Virus Paradigm. Viruses. 2014;6:2416–2427. doi: 10.3390/v6062416. - DOI - PMC - PubMed
    1. Ladronka R.M., Ainsworth S., Wilkins M.J., Norby B., Byrem T.M., Bartlett P.C. Prevalence of Bovine Leukemia Virus Antibodies in US Dairy Cattle. Vet. Med. Int. 2018;2018:33–36. doi: 10.1155/2018/5831278. - DOI - PMC - PubMed
    1. Bartlett P., Michigan State University Bovine Leukemia Virus in the U.S.: Impact and Options for Control #1 What Is It? Why Does It Matter? What Options for Control? Where to Start? What Can USAHA Do? [(accessed on 14 September 2021)]. Available online: https://blv.msu.edu/resources/USAHA-Oct-16-2017.pdf.
    1. Gao A., Kouznetsova V.L., Tsigelny I.F. Bovine Leukemia Virus Relation to Human Breast Cancer: Meta-Analysis. Microb. Pathog. 2020;149:104417. doi: 10.1016/j.micpath.2020.104417. - DOI - PMC - PubMed
    1. Buehring G.C., Delaney A., Shen H., Chu D.L., Razavian N., Schwartz D.A., Demkovich Z.R., Bates M.N. Bovine Leukemia Virus Discovered in Human Blood. BMC Infect. Dis. 2019;19:297. doi: 10.1186/s12879-019-3891-9. - DOI - PMC - PubMed

LinkOut - more resources